XENEXenon Pharmaceuticals Inc.

$5B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$5M

Operating Income

-$8M

Net Income

-$8M

EPS (Diluted)

$-0.55

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$700,000

Balance Sheet

Total Assets

$65M

Total Liabilities

$15M

Stockholders' Equity

$51M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$15,000	-100.0%
Gross Profit	-$5M	-$6M	+11.1%
Operating Income	-$8M	-$8M	+3.9%
Net Income	-$8M	-$7M	-5.7%

XENE Q2 2018 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena